Literature DB >> 23479032

Operability of glioblastomas: "sins of action" versus "sins of non-action".

Paolo Ferroli1, Marco Schiariti, Gaetano Finocchiaro, Andrea Salmaggi, Melina Castiglione, Francesco Acerbi, Giovanni Tringali, Mariangela Farinotti, Morgan Broggi, Cordella Roberto, Elio Maccagnano, Giovanni Broggi.   

Abstract

Despite prognosis of glioblastomas is still poor, mounting evidence suggests that more extensive surgical resections are associated with longer life expectancy. However, the surgical indications, at present, are far from uniform and the concept of operability is extremely surgeon-dependant. The results of glioblastoma resection in 104 patients operated on between March 2005 and April 2011 were reviewed with the aim to shed some light on the limits between 'sins of action' (operating upon complex tumors causing a permanent severe deficit) and 'sins of non-action' (considering inoperable tumors that can be resected with good results). Fifty-five patients (54.4 %) (Group 1) presented with a 'disputable' surgical indication because of one or more of the following clinico-radiological aspects: involvement of motor and language areas (39.4 %), deep location (7.7 %), corpus callosum infiltration (13.4 %), or major vessels encasement (8.6 %). Forty-six (42.5 %) patients (Group 2) presented with an 'indisputable' surgical indication (readily accessible tumors in non-eloquent areas). Overall mortality was 2.9 %. The mean overall survival was 19.8 months and not significantly different in the two Groups (20.4 Group 2 and 19.5 months for Group 1; p = 0.7). Patients with GTR and <72 years had a longer survival (p = 0.004 and 0.03, respectively). Seventy patients (69.3 %) showed an uneventful post-operative course, without statistical significance difference between Group 1 and 2. The gross total removal of glioblastoma with many complexities (Group 1) was found to be feasible with acceptable mortality, morbidity and long-term survival rates.

Entities:  

Mesh:

Year:  2013        PMID: 23479032     DOI: 10.1007/s10072-013-1345-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  31 in total

1.  Survival and treatment patterns of glioblastoma in the elderly: a population-based study.

Authors:  Sasha Gulati; Asgeir Store Jakola; Tom Børge Johannesen; Ole Solheim
Journal:  World Neurosurg       Date:  2011-12-10       Impact factor: 2.104

2.  Guidelines for the treatment of newly diagnosed glioblastoma: introduction.

Authors:  Jeffrey J Olson; Timothy Ryken
Journal:  J Neurooncol       Date:  2008-05-23       Impact factor: 4.130

3.  The dawn of the hodotopic era in neurosurgery: is there a need to upgrade the operability criteria for brain tumors?

Authors:  Paolo Ferroli; Francesco Acerbi; Angelo Franzini
Journal:  World Neurosurg       Date:  2011 May-Jun       Impact factor: 2.104

4.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

5.  Lesions in functional ("eloquent") cortex and subcortical white matter.

Authors:  M S Berger
Journal:  Clin Neurosurg       Date:  1994

6.  Application of intraoperative indocyanine green angiography for CNS tumors: results on the first 100 cases.

Authors:  P Ferroli; F Acerbi; E Albanese; G Tringali; M Broggi; A Franzini; G Broggi
Journal:  Acta Neurochir Suppl       Date:  2011

Review 7.  Management of malignant glioma: steady progress with multimodal approaches.

Authors:  Lynn S Ashby; Timothy C Ryken
Journal:  Neurosurg Focus       Date:  2006-04-15       Impact factor: 4.047

8.  Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.

Authors:  B C Devaux; J R O'Fallon; P J Kelly
Journal:  J Neurosurg       Date:  1993-05       Impact factor: 5.115

9.  Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

Authors:  Matthew J McGirt; Kaisorn L Chaichana; Muraya Gathinji; Frank J Attenello; Khoi Than; Alessandro Olivi; Jon D Weingart; Henry Brem; Alf Redo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2009-01       Impact factor: 5.115

10.  A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme.

Authors:  Kaisorn Chaichana; Scott Parker; Alessandro Olivi; Alfredo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2010-05       Impact factor: 5.115

View more
  6 in total

1.  Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines.

Authors:  J Capellades; P Teixidor; G Villalba; C Hostalot; G Plans; R Armengol; S Medrano; A Estival; R Luque; S Gonzalez; M Gil-Gil; S Villa; J Sepulveda; J J García-Mosquera; C Balana
Journal:  Clin Transl Oncol       Date:  2016-12-22       Impact factor: 3.405

2.  Is a pretreatment radiological staging system feasible for suggesting the optimal extent of resection and predicting prognosis in glioblastoma? An observational study.

Authors:  Jaume Capellades; Josep Puig; Sira Domenech; Teresa Pujol; Laura Oleaga; Angels Camins; Carles Majós; Rocio Diaz; Christian de Quintana; Pilar Teixidor; Gerard Conesa; Gerard Plans; Josep Gonzalez; Natalia García-Balañà; Jose Maria Velarde; Carmen Balaña
Journal:  J Neurooncol       Date:  2017-12-28       Impact factor: 4.130

3.  Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019.

Authors:  Alberto Raggi; Lorenzo Monasta; Ettore Beghi; Valeria Caso; Giulio Castelpietra; Stefania Mondello; Giorgia Giussani; Giancarlo Logroscino; Francesca Giulia Magnani; Marco Piccininni; Elisabetta Pupillo; Stefano Ricci; Luca Ronfani; Paola Santalucia; Davide Sattin; Silvia Schiavolin; Claudia Toppo; Eugenio Traini; Jaimie Steinmetz; Emma Nichols; Rui Ma; Theo Vos; Valery Feigin; Matilde Leonardi
Journal:  J Neurol       Date:  2021-09-08       Impact factor: 6.682

4.  The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors?

Authors:  Kaisorn L Chaichana; Ignacio Jusue-Torres; Ana Maria Lemos; Aaron Gokaslan; Eibar Ernesto Cabrera-Aldana; Ahmed Ashary; Alessandro Olivi; Alfredo Quinones-Hinojosa
Journal:  J Neurooncol       Date:  2014-09-06       Impact factor: 4.130

5.  Survival of glioblastoma in relation to tumor location: a statistical tumor atlas of a population-based cohort.

Authors:  Even Hovig Fyllingen; Lars Eirik Bø; Ingerid Reinertsen; Asgeir Store Jakola; Lisa Millgård Sagberg; Erik Magnus Berntsen; Øyvind Salvesen; Ole Solheim
Journal:  Acta Neurochir (Wien)       Date:  2021-03-20       Impact factor: 2.216

6.  Defining the impact of adjuvant treatment on the prognosis of patients with inoperable glioblastoma undergoing biopsy only: does the survival benefit outweigh the treatment effort?

Authors:  Ronja Löber-Handwerker; Katja Döring; Christoph Bock; Veit Rohde; Vesna Malinova
Journal:  Neurosurg Rev       Date:  2022-02-23       Impact factor: 2.800

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.